Global Pneumococcal Polysaccharide Vaccine Market Professional Survey Report 2019
Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age.
The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23.
The global Pneumococcal Polysaccharide Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pneumococcal Polysaccharide Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pneumococcal Polysaccharide Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pneumococcal Polysaccharide Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pneumococcal Polysaccharide Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck & Co., Inc.
Pfizer Inc.
Glaxosmithkline Plc.
Sanofi Pasteur
China National Biotec Group
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Single Dose Vial
Pre-Filled Syringe
Segment by Application
Children (2-10 Age)
Adult (10-64 Age)
Geriatric (More Than 65 Age)
The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23.
The global Pneumococcal Polysaccharide Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pneumococcal Polysaccharide Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pneumococcal Polysaccharide Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pneumococcal Polysaccharide Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pneumococcal Polysaccharide Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Merck & Co., Inc.
Pfizer Inc.
Glaxosmithkline Plc.
Sanofi Pasteur
China National Biotec Group
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Single Dose Vial
Pre-Filled Syringe
Segment by Application
Children (2-10 Age)
Adult (10-64 Age)
Geriatric (More Than 65 Age)
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
